| In general terms, the biosensor converts a biological binding event into a digital electrical signal. This enables the biosensor to employ computer technology to analyse and define this biological event. By eliminating the visual reading or human interpretation of the result of a biochemical binding event, the biosensor is capable of producing a response which is objective, more accurate and reproducible than alternative technologies. HOW AMBRI EXTENDED THE 'BIOSENSOR' CONCEPT | Ambri has built a biological switch: a membrane which can detect the presence of specific molecules and signal their presence by triggering an electrical current. This device - the Ambri Ion Channel Switch(ICS™) Biosensor - is a two molecular layer self assembled membrane based on the ion channel gramicidin. | 
| The diagram above shows the various components of the AMBRI® Biosensor - the molecule to be detected, the antibody fragments, the linker protein steptavidin and biotin linkers, the membrane layers with included gramicidin molecules. The AMBRI® biosensor operates as a synthetic mimic of a nerve cell membrane. | The key elements in this artificial membrane are: - membrane forming molecules chemically tethered to a surface
- simple ion channels within the membrane which facilitate the transport of ions like sodium
- an ionically conducting reservoir space between the electronically conductive gold surface and the membrane to store ions when they have crossed the membrane.
- receptors such as antibodies attached to the membrane to recognise target molecules.
| 
| The detection mechanism operates by the binding of the target molecule to the antibody fragment, altering the population of conduction ion channels pairs within the tethered membrane. This results in a change in the membrane conduction. The following cartoon is useful in explaining the mechanism. It has been drawn to scale using single crystal structures of the component proteins. | 
| 
| 
| 
| 
| | Ferritin 450 kD | IgG 150 kD | Streptavidin 60 kD | TSH 23 kD | Gramacidin 2 kD | | The binding of the analyte (green molecule) to the antibody fragments (red molecules), causes them to cross-link the mobile gramicidin A ion channels to tethered sites on the membrane, preventing the formation of conducting dimers. | 
| This causes a loss of conduction of ions across the membrane between the outer solution and the inner reservoir space. This is measured as a decrease in current. This is shown on the following three graphs compared to the controls in blue. A competitive assay can also be fabricated in which the target analyte causes the population of channel dimers to increase. The addition of the biotinylated Fab fragment causes the channels to cross-link and the conduction to reduce. The addition of the analyte (such as digoxin) causes the conduction to increase. Example Responses  | The formation of the membrane is in two stages. The first stage deposits the tethered components of the ICS™ from alcohol solution. Sulphur containing compounds onto a gold coated surface. This produces the inner leaflet and part of the outer leaflet of the lipid bilayer membrane, all of which is tethered to the gold surface. Following an alcohol rinse the second stage introduces the non tethered mobile components of the membrane. | 
| | 
| Rinsing with water spontaneously forms a molecular bilayer in which the inner lipid leaflet is tethered to the gold and some of which spans the membrane and comprises part of the outer lipid leafet. The remainder of the outer layer leaflet is mobile within the two dimensional plane of the membrane. Streptavidin and antibody fragments are then added in the aqueous solution. | |